Literature DB >> 6745329

The identification of mixed granulocytic-erythrocytic colonies in vitro.

J E Guimaraes, J J Berney, G E Francis, A V Hoffbrand.   

Abstract

The identification of mixed granulocytic-erythrocytic colonies in culture poses special problems. First, methods based on the detection of peroxidase-like activity of red-cell hemoglobin using benzidine can give false-positive results with eosinophilic cells in colonies. Secondly, the use of the color of hemoglobin itself to identify mixed colonies prevents the detection of those colonies where the erythrocytic component is small or contains relatively little hemoglobin. We present here a new method using O-Dianisidine (O-D) to detect red-cell peroxidase activity. Subsequent staining with Luxol fast blue showed that eosinophils did not give a positive reaction with O-D. The technique also has the advantage that the whole culture gel is processed and that there is no need to pick off individual clones for identification. Using the combined stain O-D and Luxol fast blue most lineages within clones can be discriminated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745329

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

1.  Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.

Authors:  T Sato; T Maekawa; S Watanabe; K Tsuji; T Nakahata
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.

Authors:  M Uchida; K Kirito; R Shimizu; Y Miura; K Ozawa; N Komatsu
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

3.  Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells.

Authors:  E L Wilson; G E Francis
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.